Production (Stage)
Phio Pharmaceuticals Corp.
PHIO
$2.96
$0.5020.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.63M | -1.52M | -1.85M | -2.15M | -1.90M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 1.00K | 34.00K | 43.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.00K | 52.00K | 15.00K | 35.00K | 135.00K |
| Change in Net Operating Assets | 216.00K | -481.00K | 53.00K | 74.00K | -653.00K |
| Cash from Operations | -1.37M | -1.95M | -1.78M | -2.01M | -2.37M |
| Capital Expenditure | -1.00K | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 9.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 8.00K | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.36M | 2.65M | -- | -- | 2.40M |
| Repurchase of Common Stock | -1.00K | -1.00K | 0.00 | -4.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.36M | 2.65M | 0.00 | -4.00K | 2.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.00K | 692.00K | -1.78M | -2.02M | 33.00K |